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Materials and methods

SAMPLE COLLECTION AND DNA EXTRACTION
Venous blood (20 ml) was collected into 50 ml centrifuge tubes containing 5 ml of 5% EDTA, pH 8.0, as anticoagulant. The red cells were lysed and the white cell pellet collected by centrifugation. This could be stored for up to one month at -20°C before processing. DNA extraction was carried out by a method based on that of Jeanpierre.7 DNA PROBES Four intragenic DNA probes were used to detect seven different polymorphisms (fig 1) . A recombination rate of 5% was used in all risk calculations based on these probes. DNA ANALYSIS DNA (5 to 10 p.g) from the appropriate family members was digested with restriction enzymes according to the manufacturers' instructions. The resulting fragments were size fractionated by electrophoresis in 0.8% agarose gels (Bethesda Research Laboratories). The fragments were transferred to nylon membranes (Hybond-N, Amersham) by the method of Southern8 or by vacuum blotting using the Hybaid Vacuaid system. The DNA was covalently bound to the membrane by UV photocrosslinking (305 nm for 90 seconds). The probe insert was electrophoretically purified and 50 ng was labelled with a 32P-dCTP using the random hexanucleotide primer method of Feinburg and Vogelstein9 (Multiprime Kit, Amersham). Unincorporated nucleotides were removed by gel filtration on a Sephadex G-50 column and the specific activity of the probe was measured by scintillation counting (usually 5 to lOx 108 dpm/tg DNA). The membrane was incubated for a minimum of four hours at 42°C in a formamide based prehybridisation buffer (50% formamide, 0.1% Denhardt's, 1% SDS, 5 x SSPE, 5% dextran sulphate, and 400 [tg/nl sheared salmon sperm DNA). The hybridisation solution was the same without salmon sperm DNA, which was added to the labelled probe before denaturation. The membrane was hybridised at 42°C overnight and then washed in 2x SSPE at room temperature followed by 65°C washes at in- 
Conclusion
We have provided carrier estimations on 100 females from 22 DMD families using RFLP analysis. Key females were screened for heterozygosity with the probes previously described and this strategy has DMD carrier risk (%) Figure 2 Diagram illustrating the effectiveness ofRFLP analysis in providing carrier risk estimations in DMD. All risks were calculated using MLINK from LINKAGE v3.5 and risks before RFLP analysis were based on pedigree data only. Pedigree illustrating the use of haplotype analysis for carrier estimations. 
